Back to top

stock-price-change: Archive

Zacks Equity Research

Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings Growth

Arcutis Biotherapeutics (ARQT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARQTNegative Net Change ANABNegative Net Change

Zacks Equity Research

ArcBest (ARCB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ArcBest (ARCB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARCBNegative Net Change

Zacks Equity Research

Colliers International (CIGI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Colliers International (CIGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CIGINegative Net Change

Zacks Equity Research

Chime Financial, Inc. (CHYM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Chime Financial, Inc. (CHYM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CHYMNegative Net Change PJTNegative Net Change

Zacks Equity Research

Chord Energy Corporation (CHRD) Earnings Expected to Grow: Should You Buy?

Chord Energy Corporation (CHRD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CHRDPositive Net Change SMNegative Net Change

Zacks Equity Research

Cava Group (CAVA) Reports Next Week: What Awaits?

Cava (CAVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAVANegative Net Change

Zacks Equity Research

Camtek (CAMT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Camtek (CAMT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAMTNegative Net Change

Zacks Equity Research

Dutch Bros (BROS) Earnings Expected to Grow: Should You Buy?

Dutch Bros (BROS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BROSNegative Net Change YUMPositive Net Change

Zacks Equity Research

Dave Inc. (DAVE) Reports Next Week: Wall Street Expects Earnings Growth

DAVE INC (DAVE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DAVENegative Net Change

Zacks Equity Research

Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Should You Buy?

Cytokinetics (CYTK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CYTKNegative Net Change TVTXNegative Net Change